17.01.2019 Symrise AG  DE000SYM9999

DGAP-News: Symrise updates long-term targets and aims to further expand its business until 2025


 

DGAP-News: Symrise AG / Key word(s): Strategic Company Decision/Forecast
Symrise updates long-term targets and aims to further expand its business until 2025

17.01.2019 / 14:30
The issuer is solely responsible for the content of this announcement.


  • Target corridor of 5 to 7 % for average annual sales growth (CAGR)
  • Increased profitability with EBITDA margin in the range of 20 to 23 % from 2020 onward
  • Continuation of successful strategy
  • Expansion of portfolio and sharpening the product mix: focus on high-margin applications
  • Updated targets for sustainability balance planned


Symrise AG announces its new long-term targets until 2025 for the first time at its Investors' Day in Charleston, South Carolina, USA. The Company aims to increase its sales to EUR 5.5 to 6 billion. This target is supposed to be achieved with an average annual organic sales growth (CAGR) of 5 to 7 % and strategic acquisitions. During that period, profitability is planned to be further increased at a high level. From 2020 onward, Symrise intends to generate an EBITDA margin within the target corridor of 20 to 23 %. At the same time, Symrise will remain fully committed to its proven strategy. As in the past, the Company will focus closely on customer and consumer needs and convert market trends into concrete business opportunities at the earliest possible stage. Existing strengths such as the comprehensive product portfolio should be used and expanded in a targeted manner. Symrise plans to focus in particular on innovative and high-margin applications. The Company intends to identify and enter growth opportunities in the areas of naturalness and health. Digital business processes will also contribute to the growth strategy.
 

"We look back on the development of Symrise with pride. We have achieved dynamic growth and doubled our sales from 2008 to 2017 to EUR 3 billion. For 2025, we have set the target to increase sales to EUR 5.5 to 6 billion. Our strategy, with its three pillars growth, efficiency and portfolio, has proven its worth. It is the foundation for our long-term, profitable growth", said Dr. Heinz-Jürgen Bertram, CEO of Symrise AG. "We will make even more systematic use of our strengths and enter adjacent growth areas, concentrating on the expansion of our global presence and our portfolio in high-margin business areas. We will also consistently expand our product mix, in particular with natural and health-related applications."

Olaf Klinger, CFO of Symrise AG, added: "With our targeted investments in future growth and our reinforced focus on cash flow, we will create a solid basis for the Symrise stock to remain an attractive investment for our shareholders. We will further keep an eye on our healthy capital base."


Securing long-term profitable growth

Symrise has built its updated, long-term plan on a strong foundation. With targeted investments, the Company intends to expand in high-growth business areas and to broaden its own natural raw material base. Symrise plans to further develop especially high-demand application areas such as Menthol, Cosmetic Ingredients, Food and Pet Food at an accelerated pace. The Company has largely completed its current capacity expansions. It will continue to maintain a balanced customer portfolio, comprising one-third each of globally, regionally and locally active customers. In addition, Symrise remains committed to the target of generating more than half of its sales in the fast-growing Emerging Markets.

Symrise already today has a broad portfolio that is unique in the industry. The Company expanded its strategic footprint beyond the conventional Fragrance and Flavor Business at an early stage. Today, Symrise generates one third of its sales through non-traditional applications, such as pet food and baby food, probiotics, active cosmetic ingredients and functional, health-supporting ingredients. By 2025, it aims to further increase that share. Natural product solutions for body care and foods are also playing an increasingly important role, as consumers attach greater importance to conscious nutrition choices and personal care.
 

Timely commercialization of innovations and focus on digitization

Symrise will further intensify its closely linked cooperation with its customers in the coming years. Therefore, the Company is fully committed to the increasing transition from a product developer and manufacturer to a comprehensive solution provider. Through digitized and networked processes, customer needs can be precisely identified and served across the entire supply chain.

Moreover, Symrise aims to rapidly commercialize its innovation leadership. Innovative approaches, for example using Artificial Intelligence for the creation of fine fragrances, should lead to new, market-ready products. The Company also wants to stronger cross-link the various application areas of its portfolio and use the knowledge transfer to drive innovation.
 

Outlook - long-term targets for 2025

Symrise intends to achieve its long-term targets through to the end of the fiscal year 2025 with targeted investments in additional organic growth and strategic acquisitions. The Company aims to increase sales to EUR 5.5 to 6 billion. The average annual organic sales growth is targeted in the range of 5 to 7 %. Symrise remains committed to generating more than half of its sales in Emerging Markets. With its favorable product mix and efficiency improvements, Symrise aims to generate an EBITDA margin in the range of 20 to 23 %. Most of the major investment projects will be completed by 2022. As a result, the Company aims to lower CAPEX to the range of 4 to 5 % by 2025. The Company will continue to create sustainable value for its investors and retain a dividend policy with a pay-out ratio of 30 to 50 %. In all aspects of its business activities, Symrise will remain committed to its sustainability targets and will therefore strive to reduce its ecological footprint by 50 %.
 

https://www.symrise.com/investors/financial-calendar-and-presentations/
 

About Symrise:

Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, the pharmaceutical industry and producers of nutritional supplements and pet food.

Its sales of approximately EUR 3 billion in the 2017 fiscal year make Symrise a leading global provider in the flavors and fragrances market. Headquartered in Holzminden, Germany, the Group is represented with over 90 sites in Europe, Africa, the Middle East, Asia, the United States and Latin America.

Symrise works with its clients to develop new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise - always inspiring more .

www.symrise.com

 

Media contact: Investor contact:
Bernhard Kott Tobias Erfurth
Tel.: +49 (0)5531 90-1721 Tel.: +49 (0)5531 90-1879
Email: [email protected] Email: [email protected]
 

 

Social media:

twitter.com/symriseag
linkedin.com/company/symrise
youtube.com/agsymrise
xing.com/companies/symrise

 



17.01.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: [email protected]
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

767147  17.01.2019 

fncls.ssp?fn=show_t_gif&application_id=767147&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.996,29 3.154,03 3.407,85 3.520,45 3.825,69 4.618,48 4.730,19
EBITDA1,2 630,31 630,52 685,07 742,08 813,62 795,42 851,65
EBITDA-Marge3 21,04 19,99 20,10 21,08 21,27 17,22
EBIT1,4 431,59 433,97 455,35 487,51 558,96 503,98 559,36
EBIT-Marge5 14,40 13,76 13,36 13,85 14,61 10,91 11,83
Jahresüberschuss1 275,65 297,69 297,88 314,95 385,03 290,70 344,94
Netto-Marge6 9,20 9,44 8,74 8,95 10,06 6,29 7,29
Cashflow1,7 396,18 441,79 546,76 635,68 521,56 360,11 719,51
Ergebnis je Aktie8 2,06 2,08 2,12 2,22 2,70 2,00 2,44
Dividende8 0,88 0,90 0,95 0,97 1,02 1,10 0,85
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ernst & Young

INVESTOR-INFORMATIONEN
©boersengefluester.de
Symrise
WKN Kurs in € Einschätzung Börsenwert in Mio. €
SYM999 110,950 Halten 15.507,71
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
32,63 38,66 0,84 49,55
KBV KCV KUV EV/EBITDA
4,46 21,55 3,28 21,34
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,10 1,10 0,99 15.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 01.08.2024 24.10.2024 06.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
11,11% 14,81% 11,35% 11,64%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Symrise AG  ISIN: DE000SYM9999 können Sie bei EQS abrufen


Chemie , SYM999 , SY1 , XETR:SY1